Application 125151
- Type
- BLA
- Sponsor
- SHIRE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELAPRASE | IDURSULFASE | INJECTABLE; IV (INFUSION) | 6MG/3ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54092-700 | ELAPRASE | idursulfase | Takeda Pharmaceuticals America, Inc. | BLA | Current |
| 54092-700 | ELAPRASE | idursulfase | Takeda Pharmaceuticals America, Inc. | BLA | Current |
| 54092-700 | ELAPRASE | idursulfase | Takeda Pharmaceuticals America, Inc. | BLA | Current |
| 54092-700 | ELAPRASE | idursulfase | Shire US Manufacturing Inc. | BLA | Current |